Cell senescence and hypermitogenic arrest
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
A diverse range of conditions, from mitogenic stimuli to cytotoxic stress, can induce cell senescence. Here, I propose that simultaneous stimulation of mitogen-activated pathways and downstream inhibition of cyclin-dependent kinases leads, ultimately, to cell senescence. This model distinguishes between two types of growth arrest: first, exit to G0 phase, which is caused by the withdrawal of mitogens and can lead to apoptosis; and second, hypermitogenic arrest, which is stimulated by mitogens and can lead to senescence. The concept of hypermitogenic arrest defines cell senescence as a functionally active, stable and conditionally reversible state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 3×
“Furthermore, both p21 and p27 can have opposing effects on CDK4/6 and CDK2 (Sherr & Roberts, 1999).”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“In primary cells, Ras and the downstream MAPK pathways can induce senescence due to the induction of CDKIs (Missero et al., 1996; Serrano et al., 1997; Lin et al., 1998; Zhu”
BackgroundMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906 · cited 10×
“For example, DNA-damaging agents cause the induction of CDKIs (such as p21) and changes in the phosphorylation states of CDKs and, thereby, their inhibition.”
BackgroundInfluentialTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 1×
“Finally, oncogenes that act downstream of the restriction point (such as c-Myc and CDK4), and thus may overcome senescence, cooperate with hypermitogenic oncogenes (such as Ras), leading to malignant transformation (Land et al., 1983).”
BackgroundSocial controls on cell survival and cell death
Raff, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,604 · cited 2×
“Senescence may result from telomere shortening, which occurs during each cell cycle in some cell types, but senescence does not occur in others unless they are cultured under inadequate conditions (Mathon et al., 2001; Tang et al., 2001).”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 3×
“Senescence may result from telomere shortening, which occurs during each cell cycle in some cell types, but senescence does not occur in others unless they are cultured under inadequate conditions (Mathon et al., 2001; Tang et al., 2001).”
BackgroundA Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415 · cited 1×
“This point in late G1 phase is known as the ‘restriction point’ (Pardee, 1974).”
BackgroundLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945 · cited 3×
“Upstream and downstream signalling It is assumed that cellular senescence evolved to suppress tumorigenesis (Lin et al., 1998; Campisi, 2001); that is, normal cells can”
BackgroundSenescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725 · cited 5×
“It has been suggested that premature senescence is triggered by the cumulative trauma of culturing cells in vitro (Sherr & DePinho, 2000), and also by various mitogenic, oncogenic, oxidative, cytostatic and toxic compounds, including DNA-damaging agents (McConnell et al., 1998; Lundberg et al., 2000; Roninson et al.,…”
BackgroundInfluentialWoods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639 · cited 9×
“For example, DNA-damaging agents cause the induction of CDKIs (such as p21) and changes in the phosphorylation states of CDKs and, thereby, their inhibition.”
BackgroundInfluential(1999) · PubMed · Cited by 546
High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1
Sewing, A., Wiseman, B., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 462 · cited 9×
“For example, DNA-damaging agents cause the induction of CDKIs (such as p21) and changes in the phosphorylation states of CDKs and, thereby, their inhibition.”
BackgroundInfluentialPutting the stress on senescence
Serrano, M., & Blasco, M. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00278-7 · Cited by 413 · cited 1×
“These states are referred to as spontaneous and premature senescence, respectively, and some excellent recent reviews discuss their common and divergent features (for example, see Serrano & Blasco, 2001; Hanh, 2002).”
BackgroundThe Restriction Point of the Cell Cycle
Blagosklonny, M. V., & Pardee, A. B. (2002) · Cell Cycle · doi:10.4161/cc.1.2.108 · Cited by 412 · cited 1×
“After mitogenic stimulation, cells in the G0 state enter G1, during which they induce cyclin D1 and progress through the restriction point (Blagosklonny & Pardee, 2002).”
BackgroundSelf-citationLum, D. H., Kuwabara, P. E., Zarkower, D., & Spence, A. M. (2000) · Genes & Development · doi:10.1101/gad.853700 · Cited by 391 · cited 2×
“…that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salnikow et al., 2002).”
BackgroundCellular senescence as a tumor-suppressor mechanism
Campisi, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82148-6 · Cited by 390 · cited 2×
“Upstream and downstream signalling It is assumed that cellular senescence evolved to suppress tumorigenesis (Lin et al., 1998; Campisi, 2001); that is, normal cells can”
BackgroundWang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376 · cited 1×
“Tel: +1 914 347 2801; Fax: +1 914 347 2804; E-mail: m_blagosklonny@nymc.edu Submitted 23 October 2002; accepted 30 January 2003 ©2003 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 4 | NO 4 | 2003 359 et al., 1998; Malumbres et al., 2000; Wang et al., 2002; Brookes et al., 2002).”
Regulation of cellular senescence by p53
Itahana, K., Dimri, G., & Campisi, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02228.x · Cited by 365 · cited 2×
“Senescence-inducing cytostatic stress Ionizing radiation, DNA-damaging drugs, the p53 tumour suppressor, microtubule-active drugs (such as Taxol), oxidative stress and hypoxiamimicking iron chelators, inhibitors of histone acetylase, transforming growth factor-β (TGF-β) and retinoids are all able to trigger premature…”
BackgroundThree distinct signalling responses by murine fibroblasts to genotoxic stress
Liu, Z.-G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., & Wang, J. Y. J. (1996) · Nature · doi:10.1038/384273a0 · Cited by 355 · cited 2×
“Furthermore, p53 can induce growth factors that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salni…”
BackgroundMcConnell, B. B., Starborg, M., Brookes, S., & Peters, G. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70137-x · Cited by 314 · cited 5×
“All CDKIs induce senescence when ectopically expressed in fibroblasts (McConnell et al., 1998).”
BackgroundInfluentialGenes involved in senescence and immortalization
Lundberg, A. S., Hahn, W. C., Gupta, P., & Weinberg, R. A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00155-1 · Cited by 313 · cited 2×
“It has been suggested that premature senescence is triggered by the cumulative trauma of culturing cells in vitro (Sherr & DePinho, 2000), and also by various mitogenic, oncogenic, oxidative, cytostatic and toxic compounds, including DNA-damaging agents (McConnell et al., 1998; Lundberg et al., 2000; Roninson et al.,…”
BackgroundMissero, C., Di Cunto, F., Kiyokawa, H., Koff, A., & Dotto, G. P. (1996) · Genes & Development · doi:10.1101/gad.10.23.3065 · Cited by 312 · cited 8×
“For example, DNA-damaging agents cause the induction of CDKIs (such as p21) and changes in the phosphorylation states of CDKs and, thereby, their inhibition.”
BackgroundInfluentialMathon, N. F., & Lloyd, A. C. (2001) · Nature Reviews Cancer · doi:10.1038/35106045 · Cited by 308
Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F., & Karin, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00193-8 · Cited by 295 · cited 2×
“Furthermore, p53 can induce growth factors that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salni…”
BackgroundLack of Replicative Senescence in Cultured Rat Oligodendrocyte Precursor Cells
Tang, D. G., Tokumoto, Y. M., Apperly, J. A., Lloyd, A. C., & Raff, M. C. (2001) · Science · doi:10.1126/science.1056780 · Cited by 228 · cited 1×
“Senescence may result from telomere shortening, which occurs during each cell cycle in some cell types, but senescence does not occur in others unless they are cultured under inadequate conditions (Mathon et al., 2001; Tang et al., 2001).”
BackgroundINK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence
Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf289 · Cited by 220
Agah, R., Kirshenbaum, L. A., Abdellatif, M., Truong, L. D., Chakraborty, S., Michael, L. H., & Schneider, M. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119817 · Cited by 209 · cited 2×
“, 1994), E2F1 can override ‘irreversible’ arrest in post-mitotic ventricular myocytes (Agah et al., 1997), and the E1A oncogene can reactivate the cell cycle in terminally differentiated skeletal muscle cells (Tiainen et al.”
BackgroundSalnikow, K., Kluz, T., Costa, M., Piquemal, D., Demidenko, Z. N., Xie, K., & Blagosklonny, M. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1734-1741.2002 · Cited by 207 · cited 2×
“…that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salnikow et al., 2002).”
BackgroundSelf-citationLack of Replicative Senescence in Normal Rodent Glia
Mathon, N. F., Malcolm, D. S., Harrisingh, M. C., Cheng, L., & Lloyd, A. C. (2001) · Science · doi:10.1126/science.1056782 · Cited by 185 · cited 1×
“Senescence may result from telomere shortening, which occurs during each cell cycle in some cell types, but senescence does not occur in others unless they are cultured under inadequate conditions (Mathon et al., 2001; Tang et al., 2001).”
Backgroundp16INK4a can initiate an autonomous senescence program
Dai, C. Y., & Enders, G. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203438 · Cited by 169 · cited 1×
“If p16 induction was interrupted after six days, most cells retained these morphological features (Dai & Enders, 2000).”
BackgroundHaq, R., Brenton, J. D., Takahashi, M. T., Finan, D., Finkielsztein, A., Damaraju, S., Rottapel, R. K., & Zanke, B. W. (2002) · PubMed · Cited by 165
Gire, V., & Wynford-Thomas, D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1611 · Cited by 161 · cited 1×
“Also, the inactivation of either p53 or simian virus 40 (SV40) induces senescent cells to re-enter S phase and to revert to their ‘young’ morphology (Gire & Wynford-Thomas, 1998).”
BackgroundActivation of Raf by ionizing radiation
Kasid, U. N., Suy, S., Dent, P., Ray, S., Whiteside, T. L., & Sturgill, T. W. (1996) · Nature · doi:10.1038/382813a0 · Cited by 153 · cited 2×
“Furthermore, p53 can induce growth factors that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salni…”
BackgroundCellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., Pérez De Castro, I., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 153 · cited 1×
“Tel: +1 914 347 2801; Fax: +1 914 347 2804; E-mail: m_blagosklonny@nymc.edu Submitted 23 October 2002; accepted 30 January 2003 ©2003 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 4 | NO 4 | 2003 359 et al., 1998; Malumbres et al., 2000; Wang et al., 2002; Brookes et al., 2002).”
Gong, J., Traganos, F., & Darżynkiewicz, Z. (1995) · PubMed · Cited by 150
Li, F., Li, G., Liu, G., Lee, S. W., & Aaronson, S. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1931 · Cited by 138 · cited 2×
“…that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salnikow et al., 2002).”
BackgroundPlacental cell fates are regulated in vivo by HIF-mediated hypoxia responses
Adelman, D. M., Gertsenstein, M., Nagy, A., Simon, M. C., & Maltepe, E. (2000) · Genes & Development · doi:10.1101/gad.853700a · Cited by 128
Holland, E. C., Hively, W. P., Gallo, V., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3644 · Cited by 124 · cited 6×
“We can therefore conclude that the inhibition of pathways, either at the level of CDK4/6 or downstream of CDK4/6, is essential for all forms of senescence.”
BackgroundInfluentialDas, M., Bouchey, D., Moore, M. J., Hopkins, D. C., Nemenoff, R. A., & Stenmark, K. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010690200 · Cited by 118 · cited 2×
“…that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salnikow et al., 2002).”
BackgroundA functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence
Peeper, D. S., Shvarts, A., Brummelkamp, T. R., Douma, S., Koh, E. Y., Daley, G. Q., & Bernards, R. (2002) · Nature Cell Biology · doi:10.1038/ncb742 · Cited by 111 · cited 1×
“Reactivation of cyclin E1, which acts downstream of p16, is sufficient to trigger escape from Ras-induced senescence (Peeper et al., 2002).”
BackgroundSustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53
Lee, S. W., Fang, L., Igarashi, M., Ouchi, T., Lu, K. P., & Aaronson, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150024397 · Cited by 105 · cited 2×
“Furthermore, p53 can induce growth factors that activate MAPK and Akt signalling, hypoxia causes autocrine secretion of mitogens and activation of mitogenic kinases, and DNA damage and hypoxia may, paradoxically, induce proliferation (Ishii et al., 1995; Adelman et al., 2000; Fang et al., 2001; Das et al., 2001; Salni…”
BackgroundMunro, J., Steeghs, K., Morrison, V., Ireland, H., & Parkinson, E. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204460 · Cited by 91 · cited 1×
“For example, contact inhibition of growth may be accompanied by p27 accumulation and cellular senescence (Munro et al., 2001).”
BackgroundSodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells
Terao, Y., Nishida, J.-I., Horiuchi, S., Rong, F., Ueoka, Y., Matsuda, T., Kato, H., Furugen, Y., Yoshida, K., Kato, K., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1448 · Cited by 89 · cited 1×
“This model distinguishes between two types of growth arrest: first, exit to G0 phase, which is caused by the withdrawal of mitogens and can lead to apoptosis; and second, hypermitogenic arrest, which is stimulated by mitogens and can lead to senescence.”
YOON, G., KIM, H.-J., YOON, Y.-S., CHO, H., LIM, I. K., & LEE, J.-H. (2002) · Biochemical Journal · doi:10.1042/bj20011445 · Cited by 77 · cited 2×
“The hypermitogenic arrest induced by phorbol esters is characterized by CDK inhibition in the presence of cyclin D1 (Blagosklonny, 1998), and iron chelators, contact inhibition and transforming growth factorβ induce a senescence-like late G1 arrest that is often associated with the induction of p27 (Kletsas et al., 19…”
BackgroundHigh-intensity Raf signals convert mitotic cell cycling into cellular growth.
Kerkhoff, E., & Rapp, U. R. (1998) · PubMed · Cited by 75
Tiainen, M., Spitkovsky, D., Jansen-Dürr, P., Sacchi, A., & Crescenzi, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5302 · Cited by 74 · cited 2×
“, 1997), and the E1A oncogene can reactivate the cell cycle in terminally differentiated skeletal muscle cells (Tiainen et al., 1996).”
BackgroundChalones and Cancer: Epidermal Chalone and Mitotic Control in the V × 2 Epidermal Tumour
Bullough, W. S., & Laurence, E. B. (1968) · Nature · doi:10.1038/220134a0 · Cited by 70 · cited 1×
“More than 30 years ago, it was postulated that tissues produce inhibitors, known as chalones, to control cell homeostasis (Bullough & Laurence, 1968).”
BackgroundReduction of UV-induced Cell Death in the Human Senescent Fibroblasts
Yeo, E.-J., Hwang, Y.-C., Kang, C.-M., Choy, H. E., & Park, S. C. (2000) · Molecules and Cells · doi:10.1016/s1016-8478(23)17496-6 · Cited by 61 · cited 1×
“Furthermore, senescence in fibroblasts is associated with resistance to apoptosis caused by radiation (Yeo et al., 2000).”
BackgroundInduction of Extracellular Matrix-Remodeling Genes by the Senescence-Associated Protein APA-1
Benanti, J. A., Williams, D. K., Robinson, K. L., Ozer, H. L., & Galloway, D. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7385-7397.2002 · Cited by 60 · cited 1×
“For example, senescent fibroblasts have a useful purpose: they express proteins that are normally induced on wounding, including those that remodel the extracellular matrix (Benanti et al., 2002).”
BackgroundBcl-2 can promote p53-dependent senescence versus apoptosis without affecting the G1/S transition
Rincheval, V., Renaud, F., Lemaire, C., Godefroy, N., Trotot, P., Boulo, V., Mignotte, B., & Vayssière, J.-L. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02454-3 · Cited by 46 · cited 1×
“For example, by inhibiting apoptosis, Bcl2 can promote p53-dependent senescence (Rincheval et al., 2002).”
BackgroundThe Growth-Inhibitory Block of TGF-β Is Located Close to the G1/S Border in the Cell Cycle
Kletsas, D., Stathakos, D., Sorrentino, V., & Philipson, L. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1112 · Cited by 45 · cited 1×
“…esters is characterized by CDK inhibition in the presence of cyclin D1 (Blagosklonny, 1998), and iron chelators, contact inhibition and transforming growth factorβ induce a senescence-like late G1 arrest that is often associated with the induction of p27 (Kletsas et al., 1995; Yoon et al., 2002).”
BackgroundProgression through G1 and S phases of adult rat hepatocytes
Loyer, P., Ilyin, G. P., Cariou, S., Glaise, D., Corlu, A., & Guguen‐Guillouzo, C. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_4 · Cited by 40 · cited 1×
“Interestingly, cell–cell interactions between biliary cells and hepatocytes result in the mid-G1phase arrest of hepatocytes, which are insensitive to mitogens (Loyer et al., 1996).”
BackgroundOhkubo, Y., Kishimoto, T., Nakata, T., Yasuda, H., & Endo, T. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1258 · Cited by 39 · cited 2×
“…cells of the muscle system: for example, the large-T viral oncoprotein induces the cycling of terminally differentiated skeletal muscle myotubes (Ohkubo et al., 1994), E2F1 can override ‘irreversible’ arrest in post-mitotic ventricular myocytes (Agah et al., 1997), and the E1A oncogene can…”
BackgroundMorris, M. R., Hepburn, P. J., & Wynford‐Thomas, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205492 · Cited by 39 · cited 7×
“We can therefore conclude that the inhibition of pathways, either at the level of CDK4/6 or downstream of CDK4/6, is essential for all forms of senescence.”
BackgroundInfluentialRaf-Induced Cell Cycle Progression in Human TF-1 Hematopoietic Cells
Chang, F., Steelman, L. S., & McCubrey, J. A. (2002) · Cell Cycle · doi:10.4161/cc.1.3.128 · Cited by 38 · cited 8×
“For example, DNA-damaging agents cause the induction of CDKIs (such as p21) and changes in the phosphorylation states of CDKs and, thereby, their inhibition.”
BackgroundInfluentialEnhanced mitogen-induced proliferation of rat splenocytes by low-dose whole-body X-irradiation.
Ishii, K., Yamaoka, K., Hosoi, Y., Ono, T., & Sakamoto, K. (1995) · PubMed · Cited by 36
Sherr, C. J. (2002) · Cell Cycle · doi:10.4161/cc.1.1.106 · Cited by 34 · cited 1×
“In cycling cells, Ras induces cyclin D1 in G2 phase (Sherr, 2002).”
BackgroundBlagosklonny, M. V. (1998) · International Journal of Cancer · Cited by 33
Self-citationRadiation Dose-Dependent Maintenance of G2 Arrest Requires Retinoblastoma Protein
Naderi, S., Hunton, I. C., & Wang, J. Y. J. (2002) · Cell Cycle · doi:10.4161/cc.1.3.125 · Cited by 27 · cited 1×
“DNA damage can induce permanent growth arrest in G2, which is dependent on Rb (Naderi et al., 2002).”
BackgroundMa, L., Moan, J. E., Peng, Q., & Iani, V. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981109)78:4<518::aid-ijc20>3.0.co;2-0 · Cited by 27
Self-citationSenescence, Telomere Shortening and Telomere Maintenance
Hahn, W. C. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.14 · Cited by 8
One More Reason to Get Arrested (in G1)
Darżynkiewicz, Z. (2002) · Cell Cycle · doi:10.4161/cc.1.5.146 · Cited by 3 · cited 1×
“3), and numerous anticancer drugs arrest cells when the levels of cyclins D, E, A or B are elevated (Gong et al., 1995; Darzynkiewicz, 2002).”
Background
Cited by
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
“Cellular senescence can also be induced by strong, chronic, or unbalanced mitogenic signals (44) (Figure 1), consistent with its role in suppressing tumorigenesis.”
BackgroundTGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
“Strong mitogenic activators such as activated Ras or growth factor receptor activation can provoke a shut down in the cell cycle with induction of senescence (Blagosklonny 2003; Senturk et al. 2010).”
BackgroundRapamycin decelerates cellular senescence
Demidenko, Z. N., Zubova, S. G., Bukreeva, E. I., Pospelov, V. A., Pospelova, T. V., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8606 · Cited by 391
Self-citationTai, H., Wang, Z., Gong, H., Han, X., Zhou, J., Wang, X., Wei, X., Ding, Y., Huang, N., Qin, J., et al. (2017) · Autophagy · doi:10.1080/15548627.2016.1247143 · Cited by 334
Han, X., Tai, H., Wang, X., Wang, Z., Zhou, J., Wei, X., Ding, Y., Gong, H., Mo, C., Zhang, J., et al. (2016) · Aging Cell · doi:10.1111/acel.12446 · Cited by 302
“associated with progressing cellular senescence that featured as the growth arrest, impaired function, and declined metabolism (Toussaint et al., 2000; Blagosklonny, 2003).”
Background
Metadata
- Authors
- Blagosklonny, M. V.
- Affiliations
- New York Medical College (US)
- Corresponding author
- Blagosklonny, Mikhail V
- Venue
- The EMBO Reports
- Published
- 2003-04-01
- Volume
- 4
- Issue
- 4
- Pages
- 358-362
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1319162
- OpenAlex
- W2038880350
- Cited by
- 156
- References
- 64
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 7 · 2014: 12 · 2013: 9 · 2012: 11
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, mitogen stimulation, cyclin-dependent kinases, growth arrest, apoptosis, cytotoxic stress
- MeSH terms
- Animals, Cell Cycle, Cell Division, Mitosis, Signal Transduction, Cellular Senescence, Cyclin-Dependent Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.